• Theresa Enright
  • No Comments

What do we know about the Wuhan coronavirus, 2019-nCoV?

Information regarding the novel coronavirus is rapidly evolving as scientists and public-health officials race to uncover important details on the spread and cure of the virus, which as of Monday, February 3rd has affected residents in 25 countries around the globe.

February 2, 2020 / Reuters

Thailand sees an apparent success in treating the Wuhan coronavirus with a drug cocktail comprised of anti-flu and anti-virals used to treat HIV.

February 2, 2020 / The New York Times

Experts say that the Wuhan coronavirus looks increasingly like a pandemic (an epidemic spread across two continents). Scientists, however, are uncertain as to how lethal the new coronavirus may be.

January 29, 2020 / Doherty Institute

Scientists from Melborne’s Doherty Institute are the first to grow the Wuhan coronavirus from a patient sample, which may allow accurate investigation and diagnosis of the virus globally. This is the first time the virus has been grown in cell culture outside of China.

PharPoint Research: Infectious Disease experience

PharPoint’s biostatistics and data management teams hold extensive experience participating in infectious disease clinical trials from Phase 1 to 4, including numerous study rescues.

We’ve participated in studies for infectious disease indications including HIV-1 and Influenza, among others.

PharPoint’s biostatistics team has participated in 230+ infectious disease studies as of February 2020. For more information on our biostatistics, data management, and clinical operations services, reach out to a PharPoint representative.

Author: Theresa Enright

Leave a Reply